Previous reports show that the many anticancer agents such as curcumin and RL197 target Sp transcription factors and Sp-regulated genes[20-26,30-38] and thereby inhibit non-oncogene addiction by cancer cells and tumors. The gene discussed is TFF2; the disease is cancer.